SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
SELLAS Life Sciences Group, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$10.49+0.51 (+5.11%)
Close on Oct 19, 2026
- Market cap
- $1.98B
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
SELLAS Life Sciences has not reported a dividend
No dividend per share appears in SELLAS Life Sciences's annual filings since fiscal 2010.